STAAR Surgical (NASDAQ:STAA) Position Lowered by Kayne Anderson Rudnick Investment Management LLC

Kayne Anderson Rudnick Investment Management LLC lowered its position in shares of STAAR Surgical (NASDAQ:STAA - Free Report) by 88.9% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 62,962 shares of the medical instruments supplier's stock after selling 503,040 shares during the quarter. Kayne Anderson Rudnick Investment Management LLC owned about 0.13% of STAAR Surgical worth $1,529,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of STAA. MetLife Investment Management LLC raised its stake in STAAR Surgical by 6.3% during the fourth quarter. MetLife Investment Management LLC now owns 30,396 shares of the medical instruments supplier's stock worth $738,000 after acquiring an additional 1,796 shares during the period. Illinois Municipal Retirement Fund lifted its holdings in shares of STAAR Surgical by 8.3% in the 4th quarter. Illinois Municipal Retirement Fund now owns 30,144 shares of the medical instruments supplier's stock worth $732,000 after purchasing an additional 2,318 shares during the last quarter. Generali Investments Towarzystwo Funduszy Inwestycyjnych boosted its position in STAAR Surgical by 9.7% during the 4th quarter. Generali Investments Towarzystwo Funduszy Inwestycyjnych now owns 39,500 shares of the medical instruments supplier's stock valued at $959,000 after purchasing an additional 3,500 shares during the period. HighTower Advisors LLC grew its stake in STAAR Surgical by 42.6% during the 4th quarter. HighTower Advisors LLC now owns 12,956 shares of the medical instruments supplier's stock worth $315,000 after buying an additional 3,871 shares during the last quarter. Finally, LPL Financial LLC increased its position in STAAR Surgical by 45.3% in the fourth quarter. LPL Financial LLC now owns 15,994 shares of the medical instruments supplier's stock worth $388,000 after buying an additional 4,989 shares during the period. Institutional investors own 96.70% of the company's stock.

Analyst Ratings Changes

STAA has been the subject of several recent research reports. Stifel Nicolaus lowered their price target on shares of STAAR Surgical from $38.00 to $20.00 and set a "buy" rating for the company in a research report on Wednesday, February 12th. Mizuho lowered shares of STAAR Surgical from an "outperform" rating to a "neutral" rating and dropped their price target for the company from $45.00 to $17.00 in a research note on Wednesday, February 12th. Piper Sandler reduced their price objective on STAAR Surgical from $40.00 to $16.00 and set a "neutral" rating for the company in a research report on Wednesday, February 12th. Wells Fargo & Company assumed coverage on STAAR Surgical in a research report on Monday. They issued an "equal weight" rating and a $17.00 target price on the stock. Finally, William Blair lowered STAAR Surgical from an "outperform" rating to a "market perform" rating in a research report on Wednesday, February 12th. Two research analysts have rated the stock with a sell rating, nine have assigned a hold rating and one has assigned a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Hold" and an average price target of $24.25.

STAAR Surgical Stock Up 3.9 %

Shares of STAA stock opened at $17.17 on Wednesday. The stock has a 50-day simple moving average of $17.10 and a 200 day simple moving average of $23.09. The stock has a market capitalization of $846.91 million, a P/E ratio of -41.88 and a beta of 0.75. STAAR Surgical has a fifty-two week low of $13.50 and a fifty-two week high of $49.86.

Insider Buying and Selling at STAAR Surgical

In related news, major shareholder Broadwood Partners, L.P. purchased 36,532 shares of the company's stock in a transaction on Friday, February 14th. The shares were bought at an average price of $15.49 per share, with a total value of $565,880.68. Following the completion of the acquisition, the insider now owns 11,289,437 shares of the company's stock, valued at approximately $174,873,379.13. This represents a 0.32 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. In the last three months, insiders acquired 1,742,581 shares of company stock valued at $28,407,543. 1.00% of the stock is owned by insiders.

About STAAR Surgical

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia.

Want to see what other hedge funds are holding STAA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STAAR Surgical (NASDAQ:STAA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.